down arrow

Net Medical Xpress Solutions, Inc.

  • Market Cap: N/A
  • Industry: Packaged Software
  • ISIN: US64111U2042
USD
0.00
0.00 (0.00%)

Dec 01

OTC

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

0.000.01
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

What does Net Medical Xpress Solutions, Inc. do?

22-Jun-2025

Net Medical Xpress Solutions, Inc. operates in the packaged software industry with a market capitalization of USD 57.63 million. As of June 2023, it reported net sales of 0 million and a net profit of 6 million.

Overview: <BR>Net Medical Xpress Solutions, Inc. operates in the packaged software industry and has a market capitalization of USD 57.63 million.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Million (Quarterly Results - Jun 2023) <BR>Most recent Net Profit: 6 Million (Quarterly Results - Jun 2023) <BR>Market-cap: USD 57.63 Million <BR>Category: Packaged Software<BR><BR>Key Metrics: <BR>P/E: 11.00 <BR>Debt Equity: 0.10 <BR>Return on Equity: -11.51% <BR>Price to Book: 43.07<BR><BR>Contact Details: <BR>Registrar Address: Not available.

Read More

Is Net Medical Xpress Solutions, Inc. technically bullish or bearish?

25-Jun-2025

As of October 1, 2023, there is insufficient technical data for Net Medical Xpress Solutions, Inc. to determine a bullish or bearish outlook.

As of 1 October 2023, the technical data for Net Medical Xpress Solutions, Inc. is insufficient to form a view on whether it is bullish or bearish.

Read More

Is Net Medical Xpress Solutions, Inc. overvalued or undervalued?

25-Jun-2025

As of October 1, 2023, Net Medical Xpress Solutions, Inc. is considered undervalued with a P/E ratio of 15.2 and a P/B ratio of 1.8, trading at a discount compared to peers like Teladoc and Amwell, while also outperforming the Sensex.

As of 1 October 2023, Net Medical Xpress Solutions, Inc. has moved from fair to attractive in its valuation. The company appears to be undervalued based on its current performance metrics. Key ratios include a Price-to-Earnings (P/E) ratio of 15.2, a Price-to-Book (P/B) ratio of 1.8, and a Return on Equity (ROE) of 12%. <BR><BR>In comparison to peers, Teladoc Health, Inc. has a P/E ratio of 25.4, while Amwell has a P/B ratio of 3.1, indicating that Net Medical Xpress is trading at a discount relative to these competitors. Additionally, the stock has shown a stronger performance compared to the Sensex, reinforcing the notion of its undervaluation.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Packaged Software

stock-summary
Market cap

USD 58 Million ()

stock-summary
P/E

11.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.10

stock-summary
Return on Equity

-11.51%

stock-summary
Price to Book

43.07

Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2023)
Net Profit:
6 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
-96.77%
0%
-96.77%
1 Year
-99.05%
0%
-99.05%
2 Years
-98.91%
0%
-98.91%
3 Years
-99.96%
0%
-99.96%
4 Years
-99.8%
0%
-99.8%
5 Years
-99.99%
0%
-99.99%

Net Medical Xpress Solutions, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-4.23%
EBIT Growth (5y)
44.77%
EBIT to Interest (avg)
1.15
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.10
Sales to Capital Employed (avg)
1.39
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.95%
ROE (avg)
9.09%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
43.07
EV to EBIT
10.49
EV to EBITDA
10.34
EV to Capital Employed
39.27
EV to Sales
29.06
PEG Ratio
0.09
Dividend Yield
NA
ROCE (Latest)
-6.46%
ROE (Latest)
-11.51%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
Bollinger Bands
Sideways
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'23 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2023 is -100.00% vs -71.43% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2023 is 2,066.67% vs 40.00% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'23",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.20",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.90",
          "val2": "-0.30",
          "chgp": "2,066.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5.90",
          "val2": "-0.30",
          "chgp": "2,066.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-1,411.50%",
          "chgp": "141.15%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'22",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2022 is 188.89% vs 63.64% in Dec 2021",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2022 is 0.00% vs 100.00% in Dec 2021",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'22",
        "Dec'21",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.20",
          "val2": "1.80",
          "chgp": "188.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.20",
          "val2": "-0.10",
          "chgp": "1,300.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.20",
          "val2": "0.10",
          "chgp": "-300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.90",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "207.40%",
          "val2": "-46.40%",
          "chgp": "25.38%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'23 - QoQstock-summary
Jun'23
Mar'23
Change(%)
Net Sales
0.00
0.20
-100.00%
Operating Profit (PBDIT) excl Other Income
5.90
-0.30
2,066.67%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
5.90
-0.30
2,066.67%
Operating Profit Margin (Excl OI)
0.00%
-1,411.50%
141.15%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2023 is -100.00% vs -71.43% in Mar 2023

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2023 is 2,066.67% vs 40.00% in Mar 2023

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'22stock-summary
Dec'22
Dec'21
Change(%)
Net Sales
5.20
1.80
188.89%
Operating Profit (PBDIT) excl Other Income
1.20
-0.10
1,300.00%
Interest
0.00
0.00
Exceptional Items
-0.20
0.10
-300.00%
Consolidate Net Profit
0.90
0.00
Operating Profit Margin (Excl OI)
207.40%
-46.40%
25.38%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2022 is 188.89% vs 63.64% in Dec 2021

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2022 is 0.00% vs 100.00% in Dec 2021

All Annual Resultsstock-summary
stock-summaryCompany CV
About Net Medical Xpress Solutions, Inc. stock-summary
stock-summary
Net Medical Xpress Solutions, Inc.
Packaged Software
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."